Hbk Investments L P Dexcom Inc Transaction History

Hbk Investments L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $2.43 Million - $3.89 Million	28,238 Added 47.01%	88,307 $8.24 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $6.76 Million - $7.87 Million	60,069 New	60,069 $7.72 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $540,047 - $779,567	6,355 Added 26.9%	29,979 $3.39 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $201,563 - $248,635	2,640 Added 12.58%	23,624 $1.9 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $441,527 - $862,987	6,494 Added 44.82%	20,984 $1.56 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $313,380 - $433,696	3,331 Added 29.85%	14,490 $7.41 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $3.46 Million - $4.34 Million	-26,641 Reduced 70.48%	11,159 $5.99 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $718,367 - $977,102	-25,592 Reduced 40.37%	37,800 $4.5 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $1.31 Million - $1.81 Million	48,392 Added 322.61%	63,392 $7.59 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $350,250 - $550,800	15,000 New	15,000 $2.15 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.